Review3 Biotech2026
From intake to impact: dietary modulation of the gut-brain axis across health and neurological disease.
Review in 3 Biotech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The gut-brain axis (GBA) is an intricate, bidirectional communication network linking the gastrointestinal microbiota to the central nervous system. Mounting evidence underscores its critical role in the pathogenesis of neurological and neurodegenerative disorders. Diet serves as a primary modulator of this axis, possessing the capacity to profoundly reshape microbial diversity, metabolic output, and host-microbiota interactions. This review highlights the modulatory effects of distinct dietary patterns-specifically the Western, Mediterranean, and Ketogenic diets-on GBA signaling and overall neurological health. We comprehensively analyzed how these diets alter gut microbiota composition, influence the production of neuroactive microbial metabolites, and regulate neuroimmune signaling pathways. Furthermore, the mechanistic correlations between diet-driven microbiota alterations and the pathophysiology of neurodegenerative diseases were explored. By evaluating preclinical data on the neuroprotective potential of specific dietary components, this review underscores the therapeutic promise of microbiome-targeted dietary interventions while critically addressing the translational challenges for clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.